SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 8:36 PM ETAbout this dataData status
$27.44▼-0.18 (-0.67%)
Extended:$27.44+0.00 (+0.00%)· 8:36 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

Free Cash Flow

-$126.60M

TTM · Period ending: · USD

PBLS logo

PBLS Free Cash Flow

Latest reported-$126.60M
PBLS Free Cash Flow (-$104.49M → -$126.60M)
High-resolution chart · PNG

What is free cash flow?

Free cash flow is cash from operations after capital expenditures. It shows cash remaining after investment in long-lived assets.

Compare free cash flow

PBLS free cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Parabilis Medicines, Inc. Free Cash Flow — Annual fiscal periods (USD)
Period endingFree Cash Flow (USD)Change
-124,019,000—
-104,492,000—

Frequently asked questions: PBLS free cash flow

What is Parabilis Medicines, Inc. (PBLS)'s current free cash flow?

Parabilis Medicines, Inc. (PBLS)'s latest reported free cash flow (TTM) is -$126.60M as of Sep 30, 2026. Free cash flow is cash from operations after capital expenditures. It shows cash remaining after investment in long-lived assets.

How much historical free cash flow data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s free cash flow, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's free cash flow to peers or set an alert?

You can compare PBLS's free cash flow directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.